Barbar Ruba, Brazelton Jessica N, Carroll Karen C, Lewis Shawna, Bourdas Dimitrios, Tembo Anita, Gluck Linda, Hakim Hana, Hayden Randall T
Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Department of Pathology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Clin Infect Dis. 2023 Feb 8;76(3):e1071-e1078. doi: 10.1093/cid/ciac459.
The incidence of Clostridioides difficile infection (CDI) has been rising among hospitalized children, with poor understanding of genomic variability of C. difficile isolates in this population.
This was a retrospective cohort study of CDI in inpatient and outpatient pediatric oncology and cell transplant patients (POTPs) in 2016 and 2017. CDI cases were identified by positive C. difficile toxin polymerase chain reaction tests. Retrieved residual stool specimens were cultured anaerobically and toxin-producing C. difficile isolates underwent whole genome sequencing (WGS) followed by core genome multilocus sequence typing. Plausible time and location epidemiologic links among the closely related strains were evaluated to identify potential transmission events.
Among 226 CDI episodes in 157 patients, 202 stool samples were cultured and had positive cytotoxicity tests. Sequencing identified 33 different strain types in 162 (80%) isolates. Thirty-nine (28%) patients had multiple episodes of CDI, and 31 clusters of related isolates were identified, 15 (47%) of which involved exclusively multiple specimens from the same patient. For the 16 clusters involving multiple patients, epidemiologic investigation revealed only 2 (12.5%) clusters with potential transmission events.
WGS identified a highly diverse group of C. difficile isolates among POTPs with CDI. Although WGS identified clusters of closely related isolates in multiple patients, epidemiologic investigation of shared inpatient exposures identified potential transmission in only 2 clusters. Clostridioides difficile transmission was uncommon in this population. More than 70% of new CDI reinfections in POTPs are actually recurrences caused by a previous CDI strain.
艰难梭菌感染(CDI)在住院儿童中的发病率一直在上升,人们对该人群中艰难梭菌分离株的基因组变异性了解不足。
这是一项对2016年和2017年住院和门诊儿科肿瘤及细胞移植患者(POTP)中CDI的回顾性队列研究。通过艰难梭菌毒素聚合酶链反应检测呈阳性来确定CDI病例。对回收的残余粪便标本进行厌氧培养,对产毒素的艰难梭菌分离株进行全基因组测序(WGS),然后进行核心基因组多位点序列分型。评估密切相关菌株之间可能的时间和地点流行病学联系,以识别潜在的传播事件。
在157例患者的226次CDI发作中,对202份粪便样本进行了培养,细胞毒性试验呈阳性。测序在162株(80%)分离株中鉴定出33种不同的菌株类型。39例(28%)患者有多次CDI发作,鉴定出31个相关分离株簇,其中15个(47%)仅涉及同一患者的多个标本。对于涉及多名患者的16个簇,流行病学调查仅发现2个(12.5%)簇存在潜在传播事件。
WGS在患有CDI的POTP中鉴定出高度多样化的艰难梭菌分离株群体。尽管WGS在多名患者中鉴定出密切相关的分离株簇,但对共享住院暴露的流行病学调查仅在2个簇中发现了潜在传播。艰难梭菌传播在该人群中并不常见。POTP中超过70%的新CDI再感染实际上是由先前的CDI菌株引起的复发。